Data provided by Nasdaq. Minimum 15 minutes delayed.
|Press Releases||View All »|
10/11/16Reata Pharmaceuticals, Inc. Appoints Dawn Carter Bir as Vice President and Chief Commercial Officer
10/06/16Reata Enrolls First Patient in Phase 3 CATALYST Trial of Bardoxolone Methyl in CTD-PAH Patients and Reports Positive Interim Data From CTD-PAH Patients in Phase 2 LARIAT Trial
|Lee M. Stern, CFA|
The Trout Group
Phone: (646) 378-2922